Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Leukemia. 2009 Feb 19;23(7):1337–1341. doi: 10.1038/leu.2009.26

Table 2.

Responses for CyBorD by ITT compared to historical Lenalidomide-Dex responses after 4 cycles.

Response
category
CyborD ITT
N = 33
Len-Dex ITT
N = 34
ORR (≥PR) 29 (88%) 31 (91%)
≥ VGPR 20 (61%) 15 (44%)
PR 9 (27%) 16 (47%)

Abbreviations: N, number; ITT, intention to treat; ORR, overall response (partial response or better); ≥VGPR, very good partial response or better; PR, partial response; Rev-Dex, Lenalidomide plus high dose dexamethasone